Literature DB >> 1848607

rCBF-SPECT in brain infarction: when does it predict outcome?

M Limburg1, E A van Royen, A Hijdra, B Verbeeten.   

Abstract

We prospectively studied 26 patients with ischemic stroke within 24 hr, after 2 wk, and after 6 mo with thallium-201-diethyldithiocarbamate single-photon emission computed tomography (SPECT) and neurologic and functional assessments. The admission flow deficits correlated with outcome. The admission and 6-mo scores correlated with clinical conditions at each time. At 2 wk, the flow deficits were smaller and did not correlate with clinical parameters. Nor did the presence or absence of hyperfixation of the radiopharmaceutical. Six months after the infarct, the flow defect had decreased in 9 of 15 patients in whom three serial scans were available, with better clinical improvement than in the remaining six whose flow deficits increased. More patients in the first group had been treated randomly with the calcium-entry blocker flunarizine. SPECT imaging of rCBF within 24 hr after stroke correlates with clinical outcome and condition, whereas rCBF imaging at 2 wk after the stroke shows no clinical correlation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848607

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome.

Authors:  A E Baird; M C Austin; W J McKay; G A Donnan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

2.  Comparison of mean cerebral transit time and single-photon emission tomography for estimation of stroke outcome.

Authors:  K R Lees; C J Weir; G J Gillen; A K Taylor; C Ritchie
Journal:  Eur J Nucl Med       Date:  1995-11

Review 3.  Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.

Authors:  David J Berry; Rafael Torres Martin de Rosales; Putthiporn Charoenphun; Philip J Blower
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

4.  Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT.

Authors:  J V Bowler; J P Wade; B E Jones; K S Nijran; T J Steiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

5.  Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.

Authors:  R A Dierckx; A Dobbeleir; B A Pickut; L Timmermans; I Dierckx; A Vervaet; J Vandevivere; W Deberdt; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1995-05

6.  Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery.

Authors:  I Y Shvera; A M Cherniavsky; W Y Ussov; M P Plotnikov; A A Sokolov; V M Shipulin; V I Chernov
Journal:  Eur J Nucl Med       Date:  1995-02

7.  Signs of cerebral atrophy on single-photon emission tomography.

Authors:  C O Wong; G E Meyerrose; S Sostre
Journal:  Eur J Nucl Med       Date:  1994-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.